Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Arthritis - US

Published by: Mintel International Group Ltd.

Published: Jun. 1, 2007 - 117 Pages


Table of Contents


Scope and Themes

What you need to know

Definition

Data for this report

Abbreviations and terms

Abbreviations

Terms



Executive Summary

Arthritis: not one disease, but over a hundred

ABCs of arthritis and other musculoskeletal maladies

Widespread disease

Causes are not always known

Treatments/therapies/activities/procedures

Increasing prevalence

Advertising to the growing population of people with arthritis



Background


Introduction: types of arthritis

Osteoarthritis (OA)

Fibromyalgia

Rheumatoid arthritis (RA)

Other types of arthritis

Other musculoskeletal disorders

Repetitive motion disorders (RMDs)

Common symptoms of musculoskeletal disorders

Inflammation

Debilitation

Fatigue

Negative impact on emotional well-being

Specific functional limitations

The range of experience



Prevalence and Extent of Suffering

Introduction

Figure 1: Arthritis prevalence among adults, by age and gender, 2007

Costs of treating arthritis are a growing concern

Prevalence of severe OA, RA, chronic pain, and backache

Figure 2: Prevalence of OA, RA, chronic pain, and backache, by gender, January-October 2006

Figure 3: Prevalence of OA, RA, chronic pain, and backache, by age, January-October 2006

Figure 4: Prevalence of OA, RA, chronic pain, and backache, by race/ethnicity, January-October 2006

Ailment severity

Figure 5: Severity of OA, RA, chronic pain, and backache ailments, by gender and age, January-October 2006

Prevalence of arthritis: diagnosed vs. undiagnosed

Figure 6: Prevalence of arthritis and concern about contracting arthritis, by age, April 2007

Figure 7: Prevalence of arthritis and concern about contracting arthritis, by race/ethnicity, April 2007

Prevalence of specific types of arthritis

Figure 8: Prevalence of specific arthritis types within the arthritic population, by gender and age, April 2007

Prevalence of non-arthritis musculoskeletal disorders

Figure 9: Prevalence of specific musculoskeletal disorders not including arthritis, by age, April 2007

Anatomical site of arthritis

Figure 10: Anatomical site of arthritis, by gender, April 2007

Figure 11: Anatomical site of arthritis, by age, April 2007



Causes and Prevention

Introduction

Causes

Osteoarthritis (OA)

Fibromyalgia

Rheumatoid arthritis (RA)

Other types of arthritis

Other musculoskeletal disorders

RMDs

Prevention

Osteoarthritis

Fibromyalgia

Rheumatoid arthritis

Other types of arthritis

Other musculoskeletal disorders

RMDs



Prescription and OTC Medication

Introduction

Top-selling arthritis drugs

Figure 12: Global sales of top-selling arthritis drugs, 2004 and 2005

Figure 13: Top-selling arthritis drugs, by use, positive and negative impact

New OTC medications and brand extensions

Figure 14: Pain reliever new product launches, 2001-07

Topical pain relievers

Figure 15: Advanced Healthcare Distributors Muscle & Joint Cream

Figure 16: Activ On Topical Analgesic Ultra Strength Joint & Muscle Pain Relief

Figure 17: Procter & Gamble Thermacare HeatWraps

Figure 18: WellPatch Arthritis Pain Releiving Pads

Figure 19: EMU Lifestyles Arthritic Joint Creme

Easy to open bottles

Figure 20: CVS Pharmacy Arthritis Pain Relief Caplets

Figure 21: Bayer Healthcare Aleve Arthritis Relief Tablets

Figure 22: Tylenol Arthritis Pain EZ-Open Cap

Long-lasting formulas

Figure 23: Equate Arthritis Pain Relief caplets

Enteric coated aspirin

Figure 24: Ecotrin Aspirin Arthritis Strength

Use of prescription vs. OTC medications

Figure 25: Use of prescription and OTC medications to treat OA, RA, chronic pain, and backache, by gender, January-October 2006

OTC products gain sales as Vioxx and Bextra are pulled from the market

Reasons for not taking prescription medication

Figure 26: Reasons for not taking prescription medications, by age, April 2007

Reasons for not taking OTC medication

Figure 27: Reason for not taking OTC remedies, by gender, April 2007

Figure 28: Reasons for not taking OTC remedies, by age, April 2007

Use of pain relieving liquids, rubs, and wraps among OA, RA, chronic pain, and backache sufferers

Figure 29: Use of pain relieving liquids, rubs, or wraps to treat OA, RA, chronic pain, and backache, January-October 2006



Advertising Medications to Those with Arthritis


Introduction

NSAID TV ADS

Aleve

Figure 30: Television spot: Aleve pain reliever

Figure 31: Television spot: Aleve pain reliever

Figure 32: Television spot: Aleve pain reliever

ANALGESIC TV ADS

Capzasin

Figure 33: Television spot: Capzasin topical pain reliever

WellPatch

Figure 34: Television spot: WellPatch

Tylenol Arthritis Pain

Figure 35: Television spot: Tylenol Arthritis Pain

TNF-a INHIBITOR TV ADS

Enbrel

Figure 36: Television spot: Enbrel

Figure 37: Television spot: Two Futures

Humira

Figure 38: Television spot: Humira



Herbal Remedies and Dietary Supplements

Introduction

Bovine cartilage

Bromelain

Chondroitin sulfate

Devil’s claw

Feverfew

Fish oil

Flaxseed and flaxseed oil

Ginger

GLA (gamma-linolenic acid)

Glucosamine

Gotu kola, gotu cola, brahmi, brahmi-buti, Indian pennywort

Green tea or Chinese tea

Marijuana and cannabis-based medicine

Shark cartilage

Turmeric

Type II chicken collagen, chicken collagen, chicken type II collagen, type II collagen

White willow, willow bark, white willow bark

Reasons for not taking herbal remedies

Figure 39: Reasons for not taking herbal remedies, prescription medication or otc medication, April 2007



Treatment Via Services and Activities


Services

Arthritis therapy

Pain and stress management

Aquatic therapy/hydrotherapy

Environmental assessment

Nutrition management

Activities

Yoga

Health clubs

Swimming

Bicycling

Walking/jogging

Tai Chi

Temperature therapy

Comparison of popularity of treatments including prescription, OTC, herbal, and services

Figure 40: Treatments used, April 2007

Figure 41: Treatments used by those with diangosed arthritis, April 2007



Role of the Medical Community

Figure 42: Visits to medical practicioners in past 12 months, by condition, January-October 2006

Primary care doctor/general practitioner (GP)

Rheumatologist

Orthopedist/orthopedic surgeon

Surgery

OA surgeries

RA surgeries

Fibromyalgia surgery

Other surgeries and procedures

Figure 43: Television spot: Synvisc joint fluid treatment—surgery alternative

RMD surgery

Osteopath

Physical therapist

Chiropractor

Massage therapist

Acupuncturist

Attitudes towards healthcare professionals

Figure 44: Attitudes toward healthcare professionals, by condition, January-October 2006

Access to healthcare professionals

Figure 45: Lack of medical insurance, by condition, January-October 2006



Future Trends

Population of arthritics to grow by four million in next seven years

Figure 46: Prevalence of adult arthritis, by gender and age, 2012

New treatments

Gene therapy

Vaccines

Biologics

Trial phase drugs

RA treatments

Vioxx replacements

Alternative remedies

FDA requires supplement testing for purity

Early diagnosis



Appendix: Classes of Medication for Treating Arthritis

NSAIDS

Traditional NSAIDS

Description and uses

Side effects

COX-2 inhibitors

Description and uses

Side effects

Salicylates

Description and uses

Side effects

Analgesics

Description and uses

Side effects

Disease-Modifying-Anti-Rheumatic Drugs (DMARDs)

Description and uses

Side effects

Biologic response modifiers

TNF-a inhibitors

Description and uses

Side effects

Selective B-cell inhibitor

Description and uses

Side effects

IL-1 inhibitor

Description and uses

Side effects

Selective costimulation modulator

Description and uses

Side effects

Corticosteroids

Description and uses

Side effects

Fibromyalgia drugs

Description and uses

Side effects

Gout drugs

Description and uses

Side effects



Appendix: Trade Associations

Abstract

This report covers the prevalence, incidence, costs, causes, prevention, and treatments of arthritis. Comprised of more than 100 distinct conditions, Arthritis affects approximately 50 million Americans. There are seven different drug classes (including over-the-counter and prescription medications) that treat various types of arthritis. In spite of the variety of options available, the need continues for new alternatives.

This report provides rates of use for a wide array of treatments, including traditional medications, herbal remedies, therapies, and activities to reduce pain and fatigue and increase mobility.

Specifically, this report features in-depth discussions of:

  • The prevalence and costs of arthritis in its many forms
  • Causes and preventative behavior
  • The multitude of medical practitioners treating arthritic patients, including mainstream doctors such as rheumatologists, orthopedists, and osteopaths; as well as alternative medical professionals such as chiropractors, massage therapists, and acupuncturists
  • The treatments patients use to alleviate suffering and stop the progress of disease, ranging from pharmaceuticals to herbal remedies to therapies such as aquatic and temperature therapies
  • Attitudes and opinions of arthritis sufferers from analysis of the Simmons NCS and Mintel’s own exclusive fieldwork, focusing on condition prevalence, medication preferences, attitudes towards alternative remedies, condition severity rankings, specific sites of localized pain, and ethnic attitudes towards arthritis

Mintel also identifies key trends in the future of arthritis, including prevalence, treatment, and diagnosis.



Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008